Emily E. Fannin

568 total citations
7 papers, 435 citations indexed

About

Emily E. Fannin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Emily E. Fannin has authored 7 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Emily E. Fannin's work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (4 papers). Emily E. Fannin is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (4 papers). Emily E. Fannin collaborates with scholars based in United States and Japan. Emily E. Fannin's co-authors include Praveen Sethupathy, C. Lisa Kurtz, Jeanette Baran‐Gale, Kasey C. Vickers, Cynthia L. Toth, Daniel S. Pearson, Takayoshi Shirasaki, Robert E. Lanford, Masao Honda and Stanley M. Lemon and has published in prestigious journals such as PLoS ONE, Cancer Research and Diabetes.

In The Last Decade

Emily E. Fannin

7 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily E. Fannin United States 6 342 310 37 37 18 7 435
Meilin Ma China 6 225 0.7× 173 0.6× 30 0.8× 31 0.8× 21 1.2× 6 317
Stephan Laggai Germany 10 257 0.8× 165 0.5× 28 0.8× 72 1.9× 20 1.1× 11 352
Takuma Higuchi Japan 10 282 0.8× 196 0.6× 24 0.6× 46 1.2× 22 1.2× 18 382
Monika Kolanowska Poland 11 218 0.6× 152 0.5× 27 0.7× 24 0.6× 20 1.1× 18 321
Yang Sm China 7 365 1.1× 316 1.0× 40 1.1× 34 0.9× 36 2.0× 24 478
Maryam Abbastabar Iran 8 329 1.0× 239 0.8× 30 0.8× 27 0.7× 11 0.6× 12 419
Qinghui Niu China 12 210 0.6× 160 0.5× 29 0.8× 92 2.5× 19 1.1× 27 365

Countries citing papers authored by Emily E. Fannin

Since Specialization
Citations

This map shows the geographic impact of Emily E. Fannin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily E. Fannin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily E. Fannin more than expected).

Fields of papers citing papers by Emily E. Fannin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily E. Fannin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily E. Fannin. The network helps show where Emily E. Fannin may publish in the future.

Co-authorship network of co-authors of Emily E. Fannin

This figure shows the co-authorship network connecting the top 25 collaborators of Emily E. Fannin. A scholar is included among the top collaborators of Emily E. Fannin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily E. Fannin. Emily E. Fannin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Fannin, Emily E., et al.. (2020). Characterization of multicellular breast tumor spheroids using image data-driven biophysical mathematical modeling. Scientific Reports. 10(1). 11583–11583. 18 indexed citations
2.
Fannin, Emily E., et al.. (2018). Abstract 4846: Targeting BRCA1-mutated cancer cells with elesclomol. Cancer Research. 78(13_Supplement). 4846–4846. 1 indexed citations
3.
Selitsky, Sara R., Jeanette Baran‐Gale, Masao Honda, et al.. (2015). Small tRNA-derived RNAs are increased and more abundant than microRNAs in chronic hepatitis B and C. Scientific Reports. 5(1). 7675–7675. 115 indexed citations
4.
Baran‐Gale, Jeanette, C. Lisa Kurtz, Michael R. Erdos, et al.. (2015). Addressing Bias in Small RNA Library Preparation for Sequencing: A New Protocol Recovers MicroRNAs that Evade Capture by Current Methods. Frontiers in Genetics. 6. 352–352. 74 indexed citations
5.
Kurtz, C. Lisa, Emily E. Fannin, Cynthia L. Toth, et al.. (2015). Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver. Scientific Reports. 5(1). 12911–12911. 67 indexed citations
6.
Kurtz, C. Lisa, Bailey C. E. Peck, Emily E. Fannin, et al.. (2014). MicroRNA-29 Fine-tunes the Expression of Key FOXA2-Activated Lipid Metabolism Genes and Is Dysregulated in Animal Models of Insulin Resistance and Diabetes. Diabetes. 63(9). 3141–3148. 98 indexed citations
7.
Baran‐Gale, Jeanette, Emily E. Fannin, C. Lisa Kurtz, & Praveen Sethupathy. (2013). Beta Cell 5′-Shifted isomiRs Are Candidate Regulatory Hubs in Type 2 Diabetes. PLoS ONE. 8(9). e73240–e73240. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meilin Ma Breakdown of academic impact, for papers by Stephan Laggai Breakdown of academic impact, for papers by Takuma Higuchi Breakdown of academic impact, for papers by Monika Kolanowska Breakdown of academic impact, for papers by Yang Sm Breakdown of academic impact, for papers by Maryam Abbastabar Breakdown of academic impact, for papers by Qinghui Niu
Rankless by CCL
2026